Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:05 pm Sale |
2022-12-30 | 13G | Chimerix, Inc. CMRX |
Opaleye Management Inc. | 0 0.000% |
-5,580,000 (Position Closed) |
Filing History |
| 2023-02-13 4:05 pm Unchanged |
2022-12-30 | 13G | SANUWAVE Health, Inc. SNWV |
Opaleye Management Inc. | 83,810 5.690% |
0 (Unchanged) |
Filing History |
| 2023-02-13 06:11 am Purchase |
2022-12-30 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 6,075,000 7.890% |
100,200 (+1.68%) |
Filing History |
| 2023-01-20 7:09 pm Purchase |
2022-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Opaleye Management Inc. | 1,560,000 3.610% |
616,298 (+65.31%) |
Filing History |
| 2023-01-20 4:59 pm Purchase |
2022-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,775,000 12.820% |
490,000 (+14.92%) |
Filing History |
| 2023-01-20 4:53 pm Sale |
2022-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON |
Opaleye Management Inc. | 2,170,000 8.580% |
-215,000 (-9.01%) |
Filing History |
| 2022-06-10 4:05 pm Purchase |
2022-06-07 | 13D | TELA Bio, Inc. TELA |
Opaleye Management Inc. | 1,557,500 10.690% |
806,332 (+107.34%) |
Filing History |
| 2022-06-03 4:05 pm Purchase |
2022-06-01 | 13G | TELA Bio, Inc. TELA |
Opaleye Management Inc. | 751,168 5.160% |
751,168 (New Position) |
Filing History |
| 2022-02-18 4:32 pm Purchase |
2022-02-15 | 13G | Larimar Therapeutics, Inc. LRMR |
Opaleye Management Inc. | 943,702 5.320% |
943,702 (New Position) |
Filing History |
| 2022-01-31 9:02 pm Unchanged |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
Opaleye Management Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-01-31 8:41 pm Purchase |
2021-12-31 | 13G | Chimerix, Inc. CMRX |
Opaleye Management Inc. | 5,580,000 6.400% |
1,623,500 (+41.03%) |
Filing History |
| 2022-01-31 8:38 pm Sale |
2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 5,974,800 7.800% |
-535,200 (-8.22%) |
Filing History |
| 2022-01-26 11:06 am Unchanged |
2021-12-31 | 13G | SANUWAVE Health, Inc. SNWV |
Opaleye Management Inc. | 83,810 6.500% |
0 (Unchanged) |
Filing History |
| 2022-01-26 11:00 am Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Opaleye Management Inc. | 0 0.000% |
-1,487,800 (Position Closed) |
Filing History |
| 2022-01-25 9:43 pm Purchase |
2021-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,285,000 12.200% |
219,584 (+7.16%) |
Filing History |
| 2022-01-24 4:05 pm Sale |
2021-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON |
Opaleye Management Inc. | 2,385,000 9.690% |
-1,307,700 (-35.41%) |
Filing History |
| 2021-06-17 4:40 pm Purchase |
2020-12-31 | 13G | Eton Pharmaceuticals, Inc. ETON |
Opaleye Management Inc. | 3,692,700 15.070% |
52,700 (+1.45%) |
Filing History |
| 2021-02-12 5:20 pm Sale |
2020-12-31 | 13G | Stereotaxis, Inc. STXS |
Opaleye Management Inc. | 3,021,436 4.100% |
-1,091,064 (-26.53%) |
Filing History |
| 2021-02-12 5:20 pm Sale |
2020-12-31 | 13G | EDAP TMS S.A. EDAP |
Opaleye Management Inc. | 657,500 2.260% |
-1,127,500 (-63.17%) |
Filing History |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | SANUWAVE Health, Inc. SNWV |
Opaleye Management Inc. | 83,810 6.730% |
44,562 (+113.54%) |
Filing History |